Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Cell Count × 30 days × Clear all

Phase

Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Specimen Handling 86 Biopsy 67 Magnetic Resonance Spectroscopy 59 pembrolizumab 57 Cyclophosphamide 44 Nivolumab 33 venetoclax 28 fludarabine 26 Cetuximab 22 Gemcitabine 19 Radiotherapy 18 Cisplatin 18 Carboplatin 18 Ipilimumab 16 Fluorouracil 16 Bevacizumab 16 atezolizumab 15 Oxaliplatin 15 Cytarabine 15 Azacitidine 15 Paclitaxel 14 Radiosurgery 13 tislelizumab 12 X-Rays 12 Temozolomide 12 Lenalidomide 12 Dexamethasone 12 fludarabine phosphate 11 Prednisone 11 Leucovorin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05887882 2026-03-16

PNOC028

University of California, San Francisco

Phase 1 Recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡